Safety and efficacy of the transition from subcutaneous treprostinil to oral Selexipag in patients with Pulmonary arterial hypertension
Latest Information Update: 12 Jul 2017
At a glance
- Drugs Selexipag (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Therapeutic Use
- 12 Jul 2017 New trial record
- 24 May 2017 Preliminary results (n=3) presented at the 113th International Conference of the American Thoracic Society